The Children's Hospital of Philadelphia

Total investments

8

Average round size

28M

Portfolio companies

7

Rounds per year

0.05

Lead investments

2

Follow on index

0.12

Exits

3

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsHospitalMedical DeviceMedicalLife ScienceTherapeuticsBiopharmaChild Care

Summary

The Children's Hospital of Philadelphia is the famous Corporate Investor, which was founded in 1855. The leading representative office of defined Corporate Investor is situated in the Philadelphia. The venture was found in North America in United States.

The current fund was established by Francis West Lewis.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the The Children's Hospital of Philadelphia, startups are often financed by White Owl Capital Partners, Safeguard Scientifics, Kapor Capital. The meaningful sponsors for the fund in investment in the same round are BioAdvance, White Owl Capital Partners, Total Access Fund. In the next rounds fund is usually obtained by Wellington Management, Total Access Fund, T. Rowe Price.

The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Spark Therapeutics, Bainbridge Health, Velano Vascular Among the most successful fund investment fields, there are Health Care, Biopharma. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The increased amount of exits for fund were in 2015. Opposing the other organizations, this The Children's Hospital of Philadelphia works on 11 percentage points more the average amount of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations.

Show more

Investments analytics

Analytics

Total investments
8
Lead investments
2
Exits
3
Rounds per year
0.05
Follow on index
0.12
Investments by industry
  • Health Care (6)
  • Medical (4)
  • Medical Device (2)
  • Biotechnology (2)
  • Hospital (2)
  • Show 13 more
Investments by region
  • United States (7)
Peak activity year
2017
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
617M
Group Appearance index
0.75
Avg. company exit year
10
Avg. multiplicator
5.13
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Latus Bio 02 May 2024 Early Stage Venture 54M
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.